| Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage JW Park, JK Lee, KM Sheu, L Wang, NG Balanis, K Nguyen, BA Smith, ... Science 362 (6410), 91-95, 2018 | 276 | 2018 |
| STAT3 and epithelial–mesenchymal transitions in carcinomas MK Wendt, N Balanis, CR Carlin, WP Schiemann Jak-stat 3 (2), e28975, 2014 | 232 | 2014 |
| Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway N Balanis, MK Wendt, BJ Schiemann, Z Wang, WP Schiemann, CR Carlin Journal of Biological Chemistry 288 (25), 17954-17967, 2013 | 159 | 2013 |
| Pan-cancer convergence to a small-cell neuroendocrine phenotype that shares susceptibilities with hematological malignancies NG Balanis, KM Sheu, FN Esedebe, SJ Patel, BA Smith, JW Park, ... Cancer cell 36 (1), 17-34. e7, 2019 | 144 | 2019 |
| A human adult stem cell signature marks aggressive variants across epithelial cancers BA Smith, NG Balanis, A Nanjundiah, KM Sheu, BL Tsai, Q Zhang, ... Cell reports 24 (12), 3353-3366. e5, 2018 | 113 | 2018 |
| Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures NA Graham, A Minasyan, A Lomova, A Cass, NG Balanis, M Friedman, ... Molecular systems biology 13 (2), 914, 2017 | 80 | 2017 |
| The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6 MK Wendt, WK Williams, PE Pascuzzi, NG Balanis, BJ Schiemann, ... Neoplasia 17 (1), 124-133, 2015 | 54 | 2015 |
| Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges K Song, JK Minami, A Huang, SR Dehkordi, SH Lomeli, J Luebeck, ... Cancer discovery 12 (4), 1046-1069, 2022 | 47 | 2022 |
| β3 Integrin–EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells N Balanis, M Yoshigi, MK Wendt, WP Schiemann, CR Carlin Molecular biology of the cell 22 (22), 4288-4301, 2011 | 39 | 2011 |
| A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes L Wang, BA Smith, NG Balanis, BL Tsai, K Nguyen, MW Cheng, ... Proceedings of the National Academy of Sciences 117 (1), 563-572, 2020 | 29 | 2020 |
| Mutations in an innate immunity pathway are associated with poor overall survival outcomes and hypoxic signaling in cancer MM Olcina, NG Balanis, RK Kim, BA Aksoy, J Kodysh, MJ Thompson, ... Cell reports 25 (13), 3721-3732. e6, 2018 | 29 | 2018 |
| Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer N Balanis, CR Carlin Molecular and cellular endocrinology 451, 24-30, 2017 | 26 | 2017 |
| Mutual cross-talk between fibronectin integrins and the EGF receptor: Molecular basis and biological significance N Balanis, CR Carlin Cellular Logistics 2 (1), 46-51, 2012 | 23 | 2012 |
| Intracellular C4BPA levels regulate NF-κB-dependent apoptosis MM Olcina, RK Kim, NG Balanis, CG Li, R von Eyben, TG Graeber, ... IScience 23 (10), 2020 | 13 | 2020 |
| A linear mixed model approach to gene expression-tumor aneuploidy association studies DW Yao, NG Balanis, E Eskin, TG Graeber Scientific reports 9 (1), 11944, 2019 | 3 | 2019 |
| Methods for treating small cell neuroendocrine and related cancers TG Graeber, NG Balanis, ON Witte, F ESEDEBE, JW PARK US Patent App. 17/613,881, 2022 | 1 | 2022 |
| MP57-09 MOLECULAR PROFILING OF SMALL CELL BLADDER CANCER: IMPLICATIONS FOR IMMUNOTHERAPEUTIC STRATEGIES BA Smith, NG Balanis, B Tsai, JW Park, H Zhang, JW Said, TG Graeber, ... Journal of Urology 201, e816, 2019 | 1 | 2019 |
| Making Mistakes Empowers Cancer Cells NG Balanis, TG Graeber Trends in Cancer 4 (7), 461-463, 2018 | 1 | 2018 |
| Abstract A24: Fibronectin-mediated activation of Stat3 facilitates the resistance of triple negative breast cancer to EGFR-targeted therapies MK Wendt, N Balanis, C Carlin, W Schiemann Clinical Cancer Research 18 (10_Supplement), A24-A24, 2012 | 1 | 2012 |
| Specificity of CD8-Targeted Fusosomes in Human PBMCs Using Single Cell RNA and T Cell Receptor Sequencing H Iftikhar, N Balanis, C Fonseka, C Bandoro, P Cruite, S Davis, S Amatya, ... Blood 138, 3983, 2021 | | 2021 |